Patents by Inventor Mads Holten-Andersen

Mads Holten-Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER
    Publication number: 20110060529
    Abstract: The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 10, 2011
    Applicant: RIGSHOSPITALET
    Inventors: Mads Holten-Andersen, Ross W. Stephens, Hans Jørgen Nielsen, Ib Jarle Christensen, Nils Brünner
  • Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
    Patent number: 7807379
    Abstract: The present invention describes a method for determining whether an individual is likely to suffer from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: October 5, 2010
    Assignee: Rigshospitalet
    Inventors: Mads Holten-Andersen, Ross Stephens, Hans Jørgen Nielsen, Ib Jarle Christensen, Nils Brünner
  • METHOD FOR DETECTING, SCREENING, AND/OR MONITORING CANCER IN AN INDIVIDUAL
    Publication number: 20090035794
    Abstract: The invention relates to a method for screening and/or detecting and/or monitoring a cancer in an individual, said method comprising determining a first parameter represented by the concentration of TIMP-1 in at least one excreta, e.g. saliva, from the individual. The invention provides a method that without the need to use a blood sample is suitable for facilitating the early diagnosis of a cancer, monitoring the recurrence of a cancer, and/or monitoring the status of a cancer or the effect of cancer treatment in an individual.
    Type: Application
    Filed: August 7, 2008
    Publication date: February 5, 2009
    Applicant: Rigshospitalet, Public University Hospital
    Inventors: Lasse L. Hessel, Jesper Malling, Nils Brunner, Mads Holten-Andersen, Hans Jorgen Nielsen
  • Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
    Publication number: 20070020707
    Abstract: The present invention describes a method for determining whether an individual is likely to have cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.
    Type: Application
    Filed: June 9, 2006
    Publication date: January 25, 2007
    Applicant: Rigshospitalet
    Inventors: Mads Holten-Andersen, Ross Stephens, Hans Jorgen Nielsen, Ib Christensen, Nils Brunner
  • Method for detecting, screening and/or montoring a cancer in individual
    Publication number: 20060154245
    Abstract: The invention relates to a method for screening and/or detecting and/or monitoring a cancer in an individual, said method comprising determining a first parameter represented by the concentration of TIMP-1 in at least one excreta, e.g. saliva, from the individual. The invention provides a method that without the need to use a blood sample is suitable for facilitating the early diagnosis of a cancer, monitoring the recurrence of a cancer, and/or monitoring the status of a cancer or the effect of cancer treatment in an individual.
    Type: Application
    Filed: March 28, 2005
    Publication date: July 13, 2006
    Applicants: Rigshospitalet, Hvidovre Hospital
    Inventors: Lasse Hessel, Jesper Malling, Nils Brunner, Mads Holten-Andersen, Hans Nielsen
  • Method for detecting, screening and/or monitoring a cancer in an individual
    Publication number: 20060014224
    Abstract: The invention relates to a method for screening and/or detecting and/or monitoring a cancer in an individual, said method comprising determining a first parameter represented by the concentration of TIMP-1 in at least one excreta, e.g. saliva, from the individual. The invention provides a method that without the need to use a blood sample is suitable for facilitating the early diagnosis of a cancer, monitoring the recurrence of a cancer, and/or monitoring the status of a cancer or the effect of cancer treatment in an individual.
    Type: Application
    Filed: September 26, 2003
    Publication date: January 19, 2006
    Applicant: Hvidovre Hospital
    Inventors: Nils Brunner, Lasse Hessel, Jesper Malling, Mads Holten-Andersen, Hans Nielsen